Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$3.03 - $9.0 $145,440 - $432,000
-48,000 Reduced 10.0%
432,000 $3.76 Million
Q1 2023

May 15, 2023

BUY
$2.28 - $5.04 $1.09 Million - $2.42 Million
480,000 New
480,000 $1.41 Million
Q4 2021

Feb 14, 2022

BUY
$10.18 - $18.4 $305,400 - $552,000
30,000 Added 6.67%
480,000 $5.88 Million
Q1 2021

May 18, 2021

BUY
$8.89 - $14.92 $4 Million - $6.71 Million
450,000 New
450,000 $4.57 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $214M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.